Abstract
A drug discovery program aimed at identifying new antimalarial leads from a prefractionated natural product library has resulted in the purification of a new quinoline alkaloid, (2' R)-2',3'-epoxy- N-methylatanine (1), along with eight known natural products, skimmianin, γ-fagarine, maculosidine, evolitrine, dictamnine, pteleine, N-methylatanine, and werneria chromene. Compound 1 displayed 74 % inhibition at 80 µM against a chloroquine -resistant Plasmodium falciparum strain (Dd2).
© Georg Thieme Verlag KG Stuttgart · New York.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alkaloids / chemistry
-
Alkaloids / isolation & purification
-
Alkaloids / pharmacology*
-
Antimalarials / chemistry
-
Antimalarials / isolation & purification
-
Antimalarials / pharmacology*
-
Australia
-
Cell Line, Transformed
-
Cell Survival
-
Epoxy Compounds / chemistry
-
Epoxy Compounds / isolation & purification
-
Epoxy Compounds / pharmacology*
-
Humans
-
Plant Extracts / chemistry*
-
Plant Stems / chemistry
-
Plasmodium falciparum / drug effects
-
Quinolines / chemistry
-
Quinolines / isolation & purification
-
Quinolines / pharmacology*
-
Rutaceae / chemistry*
Substances
-
Alkaloids
-
Antimalarials
-
Epoxy Compounds
-
Plant Extracts
-
Quinolines
-
quinoline